お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
357845

冠動脈バイパス術:医療機器のパイプライン評価

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019

出版日: | 発行: GlobalData | ページ情報: 英文 149 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.78円
冠動脈バイパス術:医療機器のパイプライン評価
出版日: 2019年12月18日
発行: GlobalData
ページ情報: 英文 149 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、冠動脈バイパス術関連のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における近年の動向などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 冠動脈バイパス術の概要

第3章 開発中の製品

  • 冠動脈バイパス術 - パイプライン製品:開発段階別
  • 冠動脈バイパス術 - パイプライン製品:セグメント別
  • 冠動脈バイパス術 - パイプライン製品:地域 (国) 別
  • 冠動脈バイパス術 - パイプライン製品:規制経路別
  • 冠動脈バイパス術 - パイプライン製品:承認時期別 (推定)
  • 冠動脈バイパス術 - 継続中の治験

第4章 冠動脈バイパス術 - 開発中のパイプライン製品:企業別

  • 冠動脈バイパス術企業 - パイプライン製品:開発段階別
  • 冠動脈バイパス術 - パイプライン製品:開発段階別

第5章 冠動脈バイパス術 開発企業と製品の概要

  • AdvanSource Biomaterials Corporation
  • Axcelon Biopolymers Corp.
  • CardioPolymers, Inc.
  • CellProthera
  • Coromedic Ltd.
  • Cytograft Tissue Engineering, Inc.
  • Elana bv
  • Endogene Ltd
  • Graft-Loc Inc.
  • H. Lee Moffitt Cancer Center & Research Institute, Inc.
  • iiTech BV
  • Magenta Medical Inc
  • Miracor Medical Systems GmbH
  • Neograft Technologies, Inc.
  • NuVascular Technologies Inc
  • Prekubator TTO
  • Revivicor, Inc.
  • SeamVad Ltd.
  • St. Jude Medical, Inc.
  • Tengion, Inc.
  • The University of Utah
  • Tissue Regeneration Technologies, LLC
  • University College London
  • University of Arizona
  • University of California, Los Angeles

第6章 冠動脈バイパス術 - 近年の動向

第7章 付録

図表

List of Tables

  • Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • Table 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
  • Table 7: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
  • Table 8: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Table 9: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: CardioPass - Product Status
  • Table 11: CardioPass - Product Description
  • Table 12: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: BNC - PVA Based Vascular Graft - Product Status
  • Table 14: BNC - PVA Based Vascular Graft - Product Description
  • Table 15: CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Plexisyl-AF - Product Status
  • Table 17: Plexisyl-AF - Product Description
  • Table 18: Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: AvA Aortic Valve Bypass Graft System - Product Status
  • Table 20: AvA Aortic Valve Bypass Graft System - Product Description
  • Table 21: Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Shark Anastomosis Connector - Product Status
  • Table 23: Shark Anastomosis Connector - Product Description
  • Table 24: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Distal Anastomosis Device - Product Status
  • Table 26: Distal Anastomosis Device - Product Description
  • Table 27: Proximal Anastomosis Device - Product Status
  • Table 28: Proximal Anastomosis Device - Product Description
  • Table 29: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: LifeLine TEBV - CABG - Product Status
  • Table 31: LifeLine TEBV - CABG - Product Description
  • Table 32: Elana bv Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: ELANA CLIP 3.0 - Product Status
  • Table 34: ELANA CLIP 3.0 - Product Description
  • Table 35: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Graft-Loc Device - Product Status
  • Table 37: Graft-Loc Device - Product Description
  • Table 38: H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Vascular Stent - Product Status
  • Table 40: Vascular Stent - Product Description
  • Table 41: Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: CoreoGraft - Product Status
  • Table 43: CoreoGraft - Product Description
  • Table 44: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: S² Distal Anastomotic System - Product Status
  • Table 46: S² Distal Anastomotic System - Product Description
  • Table 47: S² Proximal Anastomotic System - Product Status
  • Table 48: S² Proximal Anastomotic System - Product Description
  • Table 49: McGill University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Transcatheter Aorta Pulmonary Shunt - Product Status
  • Table 51: Transcatheter Aorta Pulmonary Shunt - Product Description
  • Table 52: Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Artificial Blood Vessel - Product Status
  • Table 54: Artificial Blood Vessel - Product Description
  • Table 55: Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Sutureless Anastomotic Graft Connection Device - Product Status
  • Table 57: Sutureless Anastomotic Graft Connection Device - Product Description
  • Table 58: Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Neovaso - Product Status
  • Table 60: Neovaso - Product Description
  • Table 61: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Coronary Artery Bypass Graft - Product Status
  • Table 63: Coronary Artery Bypass Graft - Product Description
  • Table 64: RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Neo-Vessel Replacement - Coronary Artery Bypass - Product Status
  • Table 66: Neo-Vessel Replacement - Coronary Artery Bypass - Product Description
  • Table 67: Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: ROX Anastomotic Coupler System - Product Status
  • Table 69: ROX Anastomotic Coupler System - Product Description
  • Table 70: Rox Medical Inc - Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • Figure 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
目次
Product Code: GDME0879EPD

GlobalData's Medical Devices sector report, "Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Coronary Artery Bypass Graft Surgery Overview 8

3 Products under Development 9

  • 3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 9
  • 3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 10
  • 3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 11
  • 3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 12
  • 3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 13
  • 3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 14

4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies 15

  • 4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 15
  • 4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 17

5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 18

  • 5.1 AdvanSource Biomaterials Corporation Company Overview 18
    • 5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Axcelon Biopolymers Corp. Company Overview 19
    • 5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 CardioPolymers Inc Company Overview 20
    • 5.3.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 Cardious Inc Company Overview 21
    • 5.4.1 Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.5 Centre Hospitalier Universitaire de Nice Company Overview 22
    • 5.5.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.6 Coromedic Ltd. Company Overview 23
    • 5.6.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 25
    • 5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 Elana bv Company Overview 26
    • 5.8.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Graft-Loc Inc. Company Overview 27
    • 5.9.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 28
    • 5.10.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 Hancock Jaffe Laboratories Inc Company Overview 29
    • 5.11.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 iiTech BV Company Overview 30
    • 5.12.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.13 McGill University Company Overview 32
    • 5.13.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.14 Medical 21 Inc Company Overview 33
    • 5.14.1 Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.15 Myocardial Assist Systems and Technology LLC Company Overview 34
    • 5.15.1 Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.16 Neograft Technologies Inc Company Overview 35
    • 5.16.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.17 PetVivo Holdings Inc Company Overview 36
    • 5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.18 RegenMedTX LLC Company Overview 37
    • 5.18.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.19 Rox Medical Inc Company Overview 38
    • 5.19.1 Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.20 SeamVad Ltd. Company Overview 41
    • 5.20.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.21 Surg Solutions SL Company Overview 42
    • 5.21.1 Surg Solutions SL Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.22 Synovis Micro Companies Alliance Inc Company Overview 43
    • 5.22.1 Synovis Micro Companies Alliance Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.23 Thoratec Corp Company Overview 44
    • 5.23.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.24 Tissue Regeneration Technologies LLC Company Overview 45
    • 5.24.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.25 University College London Company Overview 46
    • 5.25.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.26 University Hospital Basel Company Overview 47
    • 5.26.1 University Hospital Basel Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.27 University of Arizona Company Overview 48
    • 5.27.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.28 University of California Los Angeles Company Overview 49
    • 5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.29 University of Utah Company Overview 50
    • 5.29.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 50

6 Coronary Artery Bypass Graft Surgery- Recent Developments 51

  • 6.1 Nov 19, 2019: Hancock Jaffe Medical Team to make presentations at 46th Annual VEITH Vascular Symposium 51
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 51
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 54
  • 6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 55
  • 6.5 Oct 31, 2019: Sanofi Q3 well on track 55

7 Appendix 146

  • 7.1 Methodology 146
  • 7.2 About GlobalData 149
  • 7.3 Contact Us 149
  • 7.4 Disclaimer 149
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.